Dr. Carl Gunnar Gottschalk is the Executive Director and Principal Investigator at Simmaron Research, a NV based 501-c-3 not for profit biomedical research foundation whose work focuses on ME/CFS, Long-Haul COVID and other related diseases. Dr. Gottschalk is a principal scientist and founder of Sotira Scientific. Dr. Gottschalk is a co-inventor of KEPTIDE, an intranasal peptide for the prevention and treatment of COVID-19.